Abstract:Study question: Does the presence of human papillomavirus (HPV) in semen impact seminal parameters and sperm DNA quality in white European men seeking medical help for primary couple's infertility? Summary answer: HPV seminal infections involving high-risk (HR) genotypes are associated with impaired sperm progressive motility and sperm DNA fragmentation (SDF) values. What is known already: HPV is commonly present in semen samples. However, whether the presence of HPV in semen is actually associated with impaired sperm parameters and SDF values have yet to be elucidated. Study design, size, duration: In this cross-sectional study, complete demographic, clinical and laboratory data from 729 infertile men were analysed. Participants/materials, setting, methods: Health-significant comorbidities were scored with the Charlson comorbidity index (CCI). Serum hormones and SDF index (measured by the sperm chromatin structure assay [SCSA]) were measured in every patient (SDF ≥30% was defined as pathological). Semen analysis was based on 2010 World Health Organisation reference criteria. Amplification by nested PCR was used to detect HPV-DNA sequences in semen samples. Descriptive statistics and linear regression models were used to test the association between the presence of HPV and clinical and seminal characteristics in the whole cohort. Main results and the role of chance: The overall rate of HPV positivity was 15.5% (113/729). Overall, 78/729 (10.7%) and 35/729 (4.8%) patients had HR HPV+ and low-risk HPV+, respectively. HPV16 was the most prevalent type (22.1%), followed by HPV43 (10.6%), HPV56 and HPV42 (both 8.8%). No differences were found in terms of clinical and hormonal characteristics between patients with or without seminal HPV. Sperm progressive motility was significantly lower (P = 0.01) while SDF values were higher (P = 0.005) in HPV+ men compared to those with no HPV. In particular, HR HPV+ men had lower sperm progressive motility (P = 0.007) and higher SDF values (P = 0.003) than those with a negative HPV test. Univariable analysis showed that HR HPV+ was associated with impaired sperm progressive motility (P = 0.002) and SDF values (P = 0.003). In the multivariable analysis, age, FSH levels and testicular volume were significantly associated with impaired sperm progressive motility (all P ≤ 0.04). Conversely BMI, CCI, smoking habits and HPV status were not. Only age (P = 0.02) and FSH (P = 0.01) were significantly associated with SDF, after accounting for BMI, CCI, testicular volume, smoking habits and HPV status. Limitations, reasons for caution: Main limitations are the cross-sectional design of our study and the relatively small sample size of the subgroups. Additional limitations are the lack of a control group of normal fertile men and the lack of follow-up testing to check the clearance or the persistence of HPV in semen after a 6-12 months. Wider implications of the findings: Overall, these observations point out the importance of an accurate investigation of seminal HPV presence in everyday clinical practice in the diagnostic work-up of infertile men. Study funding/competing interest(s): No external funding was used. There are no competing interests.

Impact of Human Papillomavirus (HPV) on Male and Female Fertility

The Impact of Human Papilloma Virus on Human Reproductive Health and the Effect on Male Infertility: An updated Review

Genetic instability and anti-HPV immune response as drivers of infertility associated with HPV infection

Papillomavirus infection and male infertility: A systematic review and meta-analysis

Impact of human papillomavirus and coinfection with other sexually transmitted pathogens on male infertility

Is HPV the Novel Target in Male Idiopathic Infertility? A Systematic Review of the Literature

Impact of high-risk and low-risk human papillomavirus infections on the male genital tract: effects on semen inflammation and sperm quality

Human papillomavirus and male infertility correlation analysis following World Health Organization 2021 guidelines

Male and female human papilloma virus infection and assisted reproductive technology outcomes: A comprehensive assessment from prevalence in semen to obstetric outcomes

Diffuse mucosal ganglioneuromatosis of the colon associated with adenocarcinoma.

The effect of human papilloma virus on women reproductive system, pregnancy outcome of mothers: a review

Male and Couple Fertility Impairment due to HPV-DNA Sperm Infection: Update on Molecular Mechanism and Clinical Impact—Systematic Review

Increased Risk of Infertility in Women Infected with Human Papillomavirus

Impact of human papillomavirus infection on semen parameters and reproductive outcomes

Does Human Papillomavirus Infection Do Harm To In-Vitro Fertilization Outcomes And Subsequent Pregnancy Outcomes?

Microbiota Reconstitution Does Not Cause Bone Loss in Germ-Free Mice

Association between human papillomavirus infection and sperm quality: A systematic review and a meta‐analysis

Impact of seminal low-risk human papillomavirus infection on sperm parameters of adult men

High-risk human papillomavirus in semen is associated with poor sperm progressive motility and a high sperm DNA fragmentation index in infertile men

The high-risk human papillomavirus continuum along the female reproductive tract and its relationship to infertility and endometriosis

Human papillomavirus (HPV) contamination of gynaecological equipment